# Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

> **NCT06111872** · PHASE2 · COMPLETED · sponsor: **National University of Malaysia** · enrollment: 90 (actual)

## Conditions studied

- Cholangitis
- Pancreatic Cancer
- Choledocholithiasis
- Choledochal Cyst

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Midazolam
- **DRUG:** Pethidin

## Key facts

- **NCT ID:** NCT06111872
- **Lead sponsor:** National University of Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-18
- **Primary completion:** 2024-02-27
- **Final completion:** 2024-10-25
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111872, "Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06111872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*